Effects of an inducible anti-sense c-myc gene transfer in a drug- resistant human small-cell-lung-carcinoma cell line

International Journal of Cancer

Volumn 73, Issue 4, 1997, Pages 544-550

  Van Waardenburg, Robert C A M ^a   Meijer, Coby ^a   Burger, Herman ^b   Nooter, Kees ^b   De Vries, Elisabeth G E ^a   Mulder, Nanno H ^a   De Jong, Steven ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CISPLATIN; COMPLEMENTARY DNA; DNA FRAGMENT; DOXORUBICIN; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; GENE AMPLIFICATION; GENE INDUCTION; GENE MUTATION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MUTATION; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

CARCINOMA, SMALL CELL; CELL CYCLE; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; GENE TRANSFER TECHNIQUES; GENES, MYC; GENETIC VECTORS; GENOTYPE; HUMANS; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; RNA, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031465779     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971114)73:4<544::AID-IJC15>3.0.CO;2-9     Document Type: Article

References (21)

1. COLE, M.D., The myc oncogene: its role in transformation and differentiation. Ann. Rev. Genet., 20, 361-384 (1986).
2. COLLINS, J.F., HERMAN, P., SCUCH, C. and BAGBV JR., G.C., c-myc anti-sense oligonucleotide inhibits colony-forming capacity of Colo 320 colonic-carcinoma cells. J. clin. Invest., 89, 1523-1527 (1992).
3. COOK, R.M., MILLER, Y.E. and BUNN, P.A., Small cell lung cancer: etiology, biology, clinical features, staging and treatment. Can: Probl. Cancer, 17, 71-141 (1993).
4. DAKSIS, J.I., LU, R.Y., FACCHINI, L.M., MARHIN, W.W. and PENN, L.J.Z., myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitoeen-stimulated signal transduction to cell cycle. Oncogene, 9, 3635-3645 (1994).
5. DOOLEY, S., WUNDRACK, I., BLIN, N. and WELTER, C. Coexpression pattern of c-myc-associated genes in a small cell lung cancer cell line with steady state c-myc transcription. Biochem. biophys. Res. Commm., 213, 789-795 (1995).
6. EISENMAN, R.N., myc, max and mad: a regulatory network. Advanc. Oncol., 10, 3-6 (1994).
7. EVAN, G.I. and LITTLEWOOD, T.D., The role of c-myc in cell growth. Curr. Opin. Genet. Dev., 3, 44-49 (1993).
8. KERR, D.I., PLUMB, J.A., FRESHNEY, R.I., KHAN, M.Z. and SPANDIDOS, D.A., The effect of H-ras oncogene transfection on response of mink-lung epithelial cells to growth factors and cytotoxic drugs. Anticancer Res., 11, 1349-1352 (1991).
9. KIMURA, S., MAEKAWA, T., HIRAKAWA, K., MURAKAMI, A. and ABE, T., Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res., 55, 1379-1384 (1995).
10. LARCHER, J.C., BASSEVILLE, M., VAYSSIÈRE, IL., CORDEAU-LOSSOUARN, L., CROIZT, B. and GROS, F., Growth inhibition of NIE-115 mouse neuroblastoma cells by c-myc or N-myc antisense oligonucleotides caused limited differentiation but is not coupled to neurite formation. Biochem. biophys. Res. Comm., 185, 915-924 (1992).
11. MARCU, K.B., BOSSONE, S.A. and PATEL, A.J., myc function and regulation. Ann. Rev. Biochem., 61, 809-860 (1992).
12. NIIMI, S., NAKAGAWA, K., YOKOTA, J., TSUNOKAWA, Y., NISHIO, K., TERASHIMA, Y., SHIBUYA, M., TRRADA, M. and SAJIO, N., Resistance to anti-cancer drugs in NIHT3T3 cells transfected with C-myc and/or c-H-ras genes. Brit. J. Cancer. 63, 237-241 (1991).
13. ROBINSON, L.A., SMITH, L.J., FONTAINE, M.P., KAY, H.D., MOUNTJOY, C.P. and PIRRUCCELLO, S.J., c-myc anti-sense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Ann. thorac. Surg., 60, 1583-1591 (1995).
14. SKLAR, M.D. and PROCHOWNIK, E.V., Modulation of cis-platinum resistance in Friend crythroleukemia cells by c-myc. Cancer Res., 51, 2118-2123 (1991).
15. SKLAR, M.D., THOMPSON, E., WELSH, M.J., LIEBERT, M., HARNEY, J., GROSSMAN, H.B., SMITH, M. and PROCHOWNIK, E.V., Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras-oncogene-transformed NIH3T3 cells. Mol. cell. Biol., 11, 3699-3710 (1991).
16. SPOTTS, G.D. and HANN, S.R., Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol. cell. Biol. 10, 3952-3964 (1990).
17. VAN WAARDENBURG, R.C.A.M., PRINS, J., MEUER, C., UGES, D.R.A., DE VRIES, E.G.E. and MULDER, N.H., Effects of c-myc oncogene modulation on drue resistance in human small cell lung carcinoma cell lines. Anticancer Res., 16, 1963-1970 (1996).
18. WISDOM, R. and LEE, W., The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev., 5, 232-243 (1991).
19. WOLFF, J.E., DENECKE, J. and JURGENS, H., Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. Anticancer Res., 16, 805-809 (1996).
20. ZERVOS, A.S., GYURIS, J. and BRENT, R., Mxi1, a protein that specifically interacts with max to bind myc-max recognition sites. Cell, 72, 223-232 (1993).
21. ZIJLSTRA, J.G., DE JONG, S., VAN DE GRAMPEL, J.C., DE VRIES, E.G.E. and MULDER, N.H., Different types of DNA damage caused by three aziridinyl-substituted cyclophosphazenes in a human small cell lung carcinoma cell line. Cancer Res., 46, 2726-2729 (1986).